2026-2034年全球體外診斷醫療設備（IVD）市場規模、佔有率、趨勢和成長分析報告（心臟病學和神經病學領域）

預計心臟病學和神經病學領域的體外診斷（IVD）市場將從 2025 年的 246.7 億美元成長到 2034 年的 563 億美元，2026 年至 2034 年的複合年成長率為 9.6%。

由於心血管疾病、中風和神經退化性疾病的發生率不斷上升，體外診斷（IVD）在心臟病學和神經病學領域的市場正在擴張。人口老化和久坐的生活方式加劇了疾病發生率的上升。透過先進的生物標記檢測進行早期診斷，對於改善患者的治療效果至關重要。

關鍵成長要素包括分子診斷、就地檢驗和生物標記發現等領域的技術進步。公眾健康意識的提高和預防性篩檢計畫的擴展正在加速心血管和神經系統疾病的早期發現。診斷設備製造商和醫療服務提供者之間的研究與合作正在加速技術創新。

未來，個人化醫療和人工智慧驅動的診斷工具有望變革疾病管理。隨著醫療保健覆蓋範圍的擴大，新興市場將帶來巨大的機會。隨著對快速、準確和微創診斷解決方案的需求不斷成長，心臟病學和神經病學領域的體外診斷（IVD）市場預計將實現長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球體外診斷醫療設備（IVD）市場（心臟病學和神經病學）：按產品類型分類

• 市場分析、洞察與預測
• 裝置
• 試劑和耗材
• 軟體和服務

第5章 全球體外診斷醫療設備（IVD）市場－心臟病學和神經病學：按技術分類

• 市場分析、洞察與預測
• 免疫檢測
• 分子診斷
• 血液學
• 其他

第6章 全球體外診斷醫療設備（IVD）市場在心臟病學和神經病學領域的應用：按最終用途分類

• 市場分析、洞察與預測
• 醫院
• 臨床檢查室
• 其他

第7章 全球體外診斷醫療設備（IVD）市場－心臟病學和神經病學：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • F. Hoffmann-La Roche Ltd
  • Sysmex Corporation
  • Siemens Healthineers AG
  • Quest Diagnostics Incorporated
  • Abbott
  • BD
  • Bio-Rad Laboratories Inc
  • Beckman Coulter Inc

The IVD In Cardiology And Neurology Market size is expected to reach USD 56.30 Billion in 2034 from USD 24.67 Billion (2025) growing at a CAGR of 9.6% during 2026-2034.

The in vitro diagnostics (IVD) market in cardiology and neurology is expanding due to the increasing prevalence of cardiovascular diseases, stroke, and neurodegenerative disorders. Rising aging populations and sedentary lifestyles are contributing to higher disease incidence. Early diagnosis through advanced biomarker testing is playing a crucial role in improving patient outcomes.

Key growth drivers include technological advancements in molecular diagnostics, point-of-care testing, and biomarker discovery. Increased healthcare awareness and preventive screening programs are encouraging early detection of heart and neurological conditions. Investments in research and collaboration between diagnostic companies and healthcare providers are accelerating innovation.

In the future, personalized medicine and AI-driven diagnostic tools are expected to transform disease management. Emerging markets will present significant opportunities due to expanding healthcare access. As the demand for rapid, accurate, and minimally invasive diagnostic solutions grows, the IVD market in cardiology and neurology is set for long-term expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Instruments
• Reagents & Consumables
• Software And Services

By Technology

• Immunoassays
• Molecular Diagnostics
• Hematology
• Others

By End-use

• Hospitals
• Clinical Laboratories
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, F HoffmannLa Roche Ltd, Sysmex Corporation, Siemens Healthineers AG, Quest Diagnostics Incorporated, Abbott, BD, BioRad Laboratories Inc, Beckman Coulter Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software And Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Immunoassays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Technology
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Technology
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Technology
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Technology
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Technology
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 F. Hoffmann-La Roche Ltd
  • 9.2.3 Sysmex Corporation
  • 9.2.4 Siemens Healthineers AG
  • 9.2.5 Quest Diagnostics Incorporated
  • 9.2.6 Abbott
  • 9.2.7 BD
  • 9.2.8 Bio-Rad Laboratories Inc
  • 9.2.9 Beckman Coulter Inc